Standout Papers

External validity of randomised controlled trials: “To whom do the results of this trial apply?... 2005 2026 2012 2019 1.7k
  1. External validity of randomised controlled trials: “To whom do the results of this trial apply?” (2005)
    Peter M. Rothwell The Lancet
  2. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis (2009)
    Sarah T. Pendlebury, Peter M. Rothwell The Lancet Neurology
  3. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension (2010)
    Peter M. Rothwell, Sally C. Howard et al. The Lancet
  4. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials (2010)
    Peter M. Rothwell, F.G.R. Fowkes et al. The Lancet
  5. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials (2007)
    Katayoun Vahedi, Jeannette Hofmeijer et al. The Lancet Neurology
  6. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials (2010)
    Peter M. Rothwell, Michelle Wilson et al. The Lancet
  7. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack (2007)
    S. Claiborne Johnston, Peter M. Rothwell et al. The Lancet
  8. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison (2007)
    Peter M. Rothwell, Matthew F. Giles et al. The Lancet
  9. Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials (2012)
    Peter M. Rothwell, Michelle Wilson et al. The Lancet
  10. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation (2005)
    Peter M. Rothwell The Lancet
  11. Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials (2012)
    Peter M. Rothwell, Jackie F. Price et al. The Lancet
  12. Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials (2012)
    A. Algra, Peter M. Rothwell The Lancet Oncology
  13. Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services (2004)
    Joanna Lovett, Peter M. Rothwell et al. BMJ
  14. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis (2010)
    Alastair J.S. Webb, Urs Fischer et al. The Lancet
  15. Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies (2004)
    Joanna Lovett, Andrew Coull et al. Neurology
  16. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension (2010)
    Peter M. Rothwell The Lancet
  17. Population-Based Study of Incidence and Outcome of Acute Aortic Dissection and Premorbid Risk Factor Control (2013)
    D. Howard, Amitava Banerjee et al. Circulation
  18. Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial (2018)
    J. Michael Gaziano, Carlos Brotons et al. The Lancet
  19. Effects of β blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke (2010)
    Peter M. Rothwell, Sally C. Howard et al. The Lancet Neurology
  20. Global Stroke Statistics (2013)
    Amanda G. Thrift, Dominique A. Cadilhac et al. International Journal of Stroke
  21. One-Year Risk of Stroke after Transient Ischemic Attack or Minor Stroke (2016)
    Pierre Amarenco, Philippa C. Lavallée et al. New England Journal of Medicine
  22. Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study (2019)
    Sarah T. Pendlebury, Peter M. Rothwell The Lancet Neurology
  23. Global stroke statistics (2016)
    Amanda G. Thrift, Tharshanah Thayabaranathan et al. International Journal of Stroke
  24. Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study (2015)
    Linxin Li, Gabriel Yiin et al. The Lancet Neurology
  25. Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study (2017)
    Linxin Li, Olivia Geraghty et al. The Lancet
  26. Global Stroke Statistics 2019 (2020)
    Joosup Kim, Tharshanah Thayabaranathan et al. International Journal of Stroke
  27. Global stroke statistics 2022 (2022)
    Tharshanah Thayabaranathan, Joosup Kim et al. International Journal of Stroke

Immediate Impact

6 from Science/Nature 99 standout
Sub-graph 1 of 17

Citing Papers

Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension
2023 Standout
SARS-CoV-2 is associated with changes in brain structure in UK Biobank
2022 StandoutNature
2 intermediate papers

Works of Peter M. Rothwell being referenced

BIANCA (Brain Intensity AbNormality Classification Algorithm): A new tool for automated segmentation of white matter hyperintensities
2016
Effects of β blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke
2010 Standout
and 5 more

Author Peers

Author Last Decade Papers Cites
Peter M. Rothwell 17416 16651 15978 542 44.3k
Ralph L. Sacco 17363 14652 23938 514 48.0k
Peter J. Koudstaal 12254 9480 11522 444 37.8k
Philip A. Wolf 14316 10666 36285 338 72.5k
S. Claiborne Johnston 16830 10741 10456 335 34.7k
Michael D. Hill 21791 12066 9999 905 41.7k
George Howard 11742 8671 15127 626 38.8k
Larry B. Goldstein 12370 7710 7936 382 26.9k
Harold P. Adams 23829 14644 7726 244 39.8k
Ale Algra 11442 11391 7620 533 41.4k
Graeme J. Hankey 8379 5186 15995 651 35.6k

All Works

Loading papers...

Rankless by CCL
2026